Self-acupressure and Zhan Zhuang for Symptom Cluster Management
1 other identifier
interventional
50
1 country
1
Brief Summary
The proposed study will be a 3-arm, parallel-group randomized controlled trial on the effects of self-acupressure and Zhan-Zhuang for alleviating pain, fatigue, and sleep disturbance in breast cancer survivors. Subjects will include 54 breast cancer survivors who have experienced a moderate level of pain, fatigue and sleep disturbance. All eligible subjects will be randomized into one of the three groups in a 1:1:1 ratio: Zhan Zhuang group, or self-acupressure group, or wait list control group. Subjects in the Zhan-Zhuang group will receive up to 8 weeks of the intervention consisting of a training course over two weeks followed by self-practice for 6 weeks. Those in the self-acupressure group will attend an acupressure training course for two weeks and then, will be asked to practice self-acupressure for 6 weeks. The wait list control group will be provided with delayed self-acupressure or Zhan Zhuang at the end of the study. Outcome assessment will be conducted at baseline, week 8 (post-intervention) and week 12 (4 week follow-up). Primary outcomes include pain, fatigue and sleep disturbance. Secondary outcomes include psychological distress and health-related quality of life. Qualitative data will be collected from selected participants who have received the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 15, 2024
CompletedFirst Submitted
Initial submission to the registry
May 28, 2024
CompletedFirst Posted
Study publicly available on registry
July 12, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 20, 2024
CompletedSeptember 16, 2025
June 1, 2025
4 months
May 28, 2024
September 10, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Pain(severity and interference)
Pain will be measured by the traditional Chinese version of the Brief Pain Inventory. The questionnaire has 9 items assessing pain severity and interference with activities. It is rated using a 0-10 scale (0= no pain and no interference, 10=pain as bad as one can imagine and interferes completely).
Baseline, after 8 weeks, after 12 weeks
Fatigue
Fatigue will be measured by the traditional Chinese version of the Brief Fatigue Inventory. The questionnaire has 9 items assessing pain severity and interference with activities. It is rated using a 0-10 scale (0= no pain and no interference, 10=pain as bad as one can imagine and interferes completely).
Baseline, after 8 weeks, after 12 weeks
Sleep disturbance
Sleep disturbance will be measured by the 19-item traditional Chinese version of the Pittsburgh Sleep Quality Index. The questionnaire consists of seven domains using 19 items: overall sleep quality, sleep latency, sleep duration, sleep efficiency, sleep disturbances, day dysfunction due to sleepiness, and use of sleeping medication. The global score is calculated by summing up the scores of seven domains, with a higher score indicating greater sleep disturbance.
Baseline, after 8 weeks, after 12 weeks
Secondary Outcomes (2)
Psychological distress
Baseline, after 8 weeks, after 12 weeks
Health-related quality of life
Baseline, after 8 weeks, after 12 weeks
Other Outcomes (6)
Feasibility of the study
After 12 weeks
Feasibility of the study
After 12 weeks
Feasibility of the study
After 12 weeks
- +3 more other outcomes
Study Arms (3)
Zhan-zhuang group
EXPERIMENTALThe intervention will last 8 weeks and comprise the following 1\) Two sessions of Zhan Zhuang training(2 hours per session/week, totally 4 hours) for 2 weeks. (2) self-practice of zhan-zhuang for 6 weeks (daily, at least 20 mins) at home after passing the evaluation by a Zhan-Zhuang master
Self-acupressure group
EXPERIMENTALThe intervention will last 8 weeks and comprise the following 1\) Two sessions of self-acupressure training (2 hours per session/week, totally 4 hours) for 2 weeks. (2) self-practice of acupressure for 6 weeks (daily, around 20 mins) at home after passing the evaluation by a licensed traditional Chinese medicine doctor.
Waitlist control group
NO INTERVENTIONUsual care only
Interventions
Self-acupressure as a common type of traditional Chinese medicine therapies
Eligibility Criteria
You may qualify if:
- a female adult aged 18 and older;
- a diagnosis of early-stage (Stage I, II, or III) breast cancer;
- completion of surgery, and/or chemotherapy and/or radiotherapy;
- have at least a moderate level of pain, fatigue and sleep disturbance as measured on 0-10 numerical rating scales, with a score of ≥ 3 for each symptom during the past one month;
- willing to use WhatsApp messenger for follow-ups;
- being able to communicate in Chinese
You may not qualify if:
- prior use of acupuncture, acupressure, Zhan Zhuang, or other types of Zhan Zhuang within the past three months;
- currently receiving progressive muscle relaxation, mindfulness-based stress reduction, and other body mind exercise (e.g. yoga) for the treatment of pain, fatigue, and sleep disturbance;
- mentally incapable of participating in the study as indicated by the Hong Kong version of Montreal Cognitive Assessment score;
- inability to perform self-care as indicated by the Karnofsky Performance Scale score\<70
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Hong Kong Polytechnic University (posters, Facebook, WhatsApp groups etc.)
Hong Kong, China
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 28, 2024
First Posted
July 12, 2024
Study Start
May 15, 2024
Primary Completion
September 20, 2024
Study Completion
October 20, 2024
Last Updated
September 16, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share